Key facts
- MediScan AI’s last known valuation is $12.0M (Apr 2025).
- It has raised $1.9M across 1 recorded rounds; the latest was Seed Round ($1.3M) in Jan 2025.
- Notable investors include Tidal Ventures (Australia).
- MediScan AI has filed 2 Form Ds with the SEC, most recently Apr 2025 ($1.3M sold to 2 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for MediScan AI
Funding rounds
1 roundsAbout MediScan AI
Developer of AI-powered medical record processing software intended for clinical and med-legal case review purposes. The company's platform enables users to upload large volumes of medical documents, automatically structures and organizes records into chronological timelines, generates editable summaries, provides AI-powered search and chat over records, supports collaboration and export-ready reports, and ensures secure data handling, enabling physicians, attorneys, insurers, and healthcare professionals to review cases faster, reduce manual effort, and maintain oversight in decision-making.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2024
- Employees
- 9
- Website
- mediscan.ai/
- Ownership
- Privately Held (backing)
MediScan AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MediScan AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MediScan AI in its N-PORT filings yet. We sweep new filings monthly.